419 results on '"Yan, Raymond T."'
Search Results
2. Cardiac MRI and radionuclide ventriculography for measurement of left ventricular ejection fraction in ICD candidates
3. Multislice CT
4. Clinical Characteristics, Management, and Outcomes of Acute Coronary Syndrome in Patients With Right Bundle Branch Block on Presentation
5. Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes
6. Efficacy and Safety of a Routine Early Invasive Strategy in Relation to Time from Symptom Onset to Fibrinolysis (a Subgroup Analysis of TRANSFER-AMI)
7. Proximal Aortic Distensibility Is an Independent Predictor of All-Cause Mortality and Incident CV Events: The MESA Study
8. Comparison of the Efficacy of Pharmacoinvasive Management for ST-Segment Elevation Myocardial Infarction in Smokers Versus Non-Smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction)
9. Prognostic Implications of Prominent R Wave in Electrocardiographic Leads V1 or V2 in Patients With Acute Coronary Syndrome
10. Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease
11. PTCH1 and AXIN2 modulation of AR copy number effects on AR gene overexpression in metastatic castration resistant prostate cancer (mCRPC).
12. Management and Outcomes of Non-ST Elevation Acute Coronary Syndromes in Relation to Previous Use of Antianginal Therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE])
13. Treatment and Outcomes of Patients With Suspected Acute Coronary Syndromes in Relation to Initial Diagnostic Impressions (Insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE])
14. Temporal Patterns of Lipid Testing and Statin Therapy in Acute Coronary Syndrome Patients (from the Canadian GRACE Experience)
15. Relation Between Previous Angiotensin-Converting Enzyme Inhibitor Use and In-Hospital Outcomes in Acute Coronary Syndromes
16. Regional Left Ventricular Myocardial Dysfunction as a Predictor of Incident Cardiovascular Events: MESA (Multi-Ethnic Study of Atherosclerosis)
17. Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE)
18. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non–ST-elevation acute coronary syndromes
19. Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non–ST-elevation acute coronary syndromes
20. Comparison of Baseline Characteristics, Management and Outcome of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials
21. Relation Between Hemoglobin Level and Recurrent Myocardial Ischemia in Acute Coronary Syndromes Detected by Continuous Electrocardiographic Monitoring
22. Relation Between Obesity and the Attainment of Optimal Blood Pressure and Lipid Targets in High Vascular Risk Outpatients
23. Disparities in Management Patterns and Outcomes of Patients With Non–ST-Elevation Acute Coronary Syndrome With and Without a History of Cerebrovascular Disease
24. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes
25. Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA)
26. Evaluation of left ventricular ejection fraction in non–ST-segment elevation acute coronary syndromes and its relationship to treatment
27. QRS prolongation in patients with acute coronary syndromes
28. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization
29. High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events
30. Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification
31. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience
32. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada
33. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes
34. Influence of Age on Use of Cardiac Catheterization and Associated Outcomes in Patients With Non-ST-Elevation Acute Coronary Syndromes
35. Bleeding and outcome in acute coronary syndrome: Insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial
36. Impact of delayed presentation on management and outcome of non–ST-elevation acute coronary syndromes
37. Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non–ST-segment elevation acute coronary syndromes
38. Prognostic significance of presenting blood pressure in non–ST-segment elevation acute coronary syndrome in relation to prior history of hypertension
39. Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome
40. Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndrome
41. Missed opportunities for the secondary prevention of cardiovascular disease in Canada
42. Relationship of ST elevation in lead aVR with angiographic findings and outcome in non–ST elevation acute coronary syndromes
43. Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes
44. ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratification
45. Age-related differences in the management and outcome of patients with acute coronary syndromes
46. Heterogeneity in age related central arterial stiffening: ascending aortic stiffness is a better predictor of carotid to femoral pulse wave velocity and brachial peripheral blood pressure than carotid stiffness
47. Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndrome
48. Prognostic value of myocardial circumferential strain for incident heart failure and cardiovascular events in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis
49. Pre-Hospital Cardiac Arrest in Acute Coronary Syndromes: Insights from the Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events
50. Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.